does my insurance cover glp 1 for weight loss GLP-1 Specialist in Langhorne and Philadelphia, PA How many adults with private

The composite primary endpoint occurred in 6.5% of patients in the semaglutide group versus 8.0% of patients in the placebo group (hazard ratio [HR] = 0.80

[6] Still, baseline testing may be important if you have a history of liver disease or are taking other medications metabolized by the liver

Compounded medications allow for tailored dosages

This is a big milestone for GLP-1s and for patient access more broadly

Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks